{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:56:19Z","timestamp":1793350579129,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA033391"],"award-info":[{"award-number":["R01DA033391"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.josat.2024.209334","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T20:09:26Z","timestamp":1711310966000},"page":"209334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder"],"prefix":"10.1016","volume":"162","author":[{"given":"Laura B.","family":"Monico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse B.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gryczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Gwin","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.josat.2024.209334_bb0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jadohealth.2020.03.005","article-title":"Adolescent-serving addiction treatment facilities in the United States and the availability of medications for opioid use disorder","volume":"67","author":"Alinsky","year":"2020","journal-title":"The Journal of Adolescent Health"},{"issue":"3","key":"10.1016\/j.josat.2024.209334_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5183","article-title":"Receipt of addiction treatment after opioid overdose among medicaid-enrolled adolescents and young adults","volume":"174","author":"Alinsky","year":"2020","journal-title":"JAMA Pediatrics"},{"issue":"1","key":"10.1016\/j.josat.2024.209334_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14486","article-title":"Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences","volume":"34","author":"Azhar","year":"2021","journal-title":"Dermatologic Therapy"},{"issue":"1","key":"10.1016\/j.josat.2024.209334_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13722-021-00249-3","article-title":"Receipt of medications for opioid use disorder among youth engaged in primary care: Data from 6 health systems","volume":"16","author":"Bagley","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2024.209334_bb0025","series-title":"The role of medications in the treatment of adolescents and young adults with opioid use disorder","author":"Banta-Green","year":"2018"},{"key":"10.1016\/j.josat.2024.209334_bb0030","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.jval.2020.04.824","article-title":"PMU51 provider attitudes, intention, and behavior to prescribe buprenorphine for the treatment of opioid use disorder: A systematic review","volume":"23","author":"Bapat","year":"2020","journal-title":"Value in Health"},{"issue":"3","key":"10.1016\/j.josat.2024.209334_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/ADM.0000000000000388","article-title":"Buprenorphine treatment for adolescents and young adults with opioid use disorders: A narrative review","volume":"12","author":"Borodovsky","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2024.209334_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15288\/jsad.2019.80.393","article-title":"Medications for maintenance treatment of opioid use disorder in adolescents: A narrative review and assessment of clinical benefits and potential risks","volume":"80","author":"Camenga","year":"2019","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"1","key":"10.1016\/j.josat.2024.209334_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1542\/pir.2017-0153","article-title":"Medication treatment of adolescent opioid use disorder in primary care","volume":"39","author":"Carney","year":"2018","journal-title":"Pediatrics in Review"},{"key":"10.1016\/j.josat.2024.209334_bb0050","author":"CDC Wonder"},{"key":"10.1016\/j.josat.2024.209334_bb0055","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.josat.2024.209334_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00952990.2017.1399403","article-title":"Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions","volume":"44","author":"Chang","year":"2018","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"32","key":"10.1016\/j.josat.2024.209334_bb0065","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e208","article-title":"Patient perspectives and preferences regarding gout and gout management: Impact on adherence","volume":"36","author":"Chung","year":"2021","journal-title":"Journal of Korean Medical Science"},{"issue":"3","key":"10.1016\/j.josat.2024.209334_bb0070","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1893","article-title":"Medication-assisted treatment of adolescents with opioid use disorders","volume":"138","author":"Committee on Substance Use and Prevention","year":"2016","journal-title":"Pediatrics"},{"issue":"460","key":"10.1016\/j.josat.2024.209334_bb0075","first-page":"892","article-title":"Shared decision making and the concept of equipoise: The competences of involving patients in healthcare choices","volume":"50","author":"Elwyn","year":"2000","journal-title":"The British Journal of General Practice"},{"issue":"6","key":"10.1016\/j.josat.2024.209334_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","article-title":"Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder","volume":"60","author":"Feder","year":"2017","journal-title":"The Journal of Adolescent Health"},{"issue":"1","key":"10.1016\/j.josat.2024.209334_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145817","article-title":"Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature","volume":"11","author":"Friedrichs","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.josat.2024.209334_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0749-3797(99)00097-5","article-title":"Shared decision making in clinical medicine: Past research and future directions","volume":"17","author":"Frosch","year":"1999","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209334_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000518436","article-title":"The predictive value of degree of preference for extended-release naltrexone for treatment adherence, opioid use, and relapse","volume":"28","author":"Gaulen","year":"2022","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1016\/j.josat.2024.209334_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10550490902925540","article-title":"Engagement and retention in outpatient alcoholism treatment for women","volume":"18","author":"Graff","year":"2009","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.josat.2024.209334_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-102-4-520","article-title":"Expanding patient involvement in care. Effects on patient outcomes","volume":"102","author":"Greenfield","year":"1985","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2024.209334_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.josat.2024.209334_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0277-9536(98)00059-8","article-title":"Patient participation in decision-making","volume":"47","author":"Guadagnoli","year":"1998","journal-title":"Social Science & Medicine"},{"issue":"11","key":"10.1016\/j.josat.2024.209334_bb0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatrics"},{"issue":"8","key":"10.1016\/j.josat.2024.209334_bb0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.josat.2024.209334_bb0130","article-title":"Years of life lost to unintentional drug overdose rapidly rising in the adolescent population, 2016-2020","author":"Hermans","year":"2022","journal-title":"The Journal of Adolescent Health"},{"issue":"2","key":"10.1016\/j.josat.2024.209334_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1377\/hlthaff.2012.1078","article-title":"Shared decision making: Examining key elements and barriers to adoption into routine clinical practice","volume":"32","author":"L\u00e9gar\u00e9","year":"2013","journal-title":"Health Affairs (Millwood)"},{"key":"10.1016\/j.josat.2024.209334_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.33393\/dti.2021.2342","article-title":"The role of patient preferences in adherence to treatment in chronic disease: A narrative review","volume":"15","author":"Losi","year":"2021","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.josat.2024.209334_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108407","article-title":"Extended-release naltrexone for youth with opioid use disorder","volume":"130","author":"Mitchell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209334_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13011-015-0009-2","article-title":"Implementing buprenorphine in addiction treatment: Payer and provider perspectives in Ohio","volume":"10","author":"Molfenter","year":"2015","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2024.209334_bb0155","author":"National Center for Health Statistics"},{"key":"10.1016\/j.josat.2024.209334_bb0160","author":"National Center for Injury Prevention and Control"},{"key":"10.1016\/j.josat.2024.209334_bb0165","author":"National Institute on Drug Abuse"},{"issue":"6","key":"10.1016\/j.josat.2024.209334_bb0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40272-013-0041-5","article-title":"Pharmacologically assisted treatment of opioid-dependent youth","volume":"15","author":"Pecoraro","year":"2013","journal-title":"Pediatric Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.josat.2024.209334_bb0175","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1542\/peds.2019-2056C","article-title":"Management of opioid misuse and opioid use disorders among youth","volume":"145","author":"Robinson","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.josat.2024.209334_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jclp.20553","article-title":"The impact of client treatment preferences on outcome: A meta-analysis","volume":"65","author":"Swift","year":"2009","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.josat.2024.209334_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients\u2019 beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209334_bb0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsat.2017.08.007","article-title":"Home-based delivery of XR-NTX in youth with opioid addiction","volume":"85","author":"Vo","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2024.209334_bb0195","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jpepsy\/jsy087","article-title":"The relationship of adolescent and parent preferences for treatment modality with satisfaction, attrition, adherence, and efficacy: The coping with head injury through problem-solving (CHIPS) study","volume":"44","author":"Wade","year":"2019","journal-title":"Journal of Pediatric Psychology"},{"key":"10.1016\/j.josat.2024.209334_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108149","article-title":"Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency","volume":"120","author":"Wenzel","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209334_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108306","article-title":"Choice of extended-release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the youth opioid recovery support (YORS) intervention","volume":"125","author":"Wenzel","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"17","key":"10.1016\/j.josat.2024.209334_bb0210","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.josat.2024.209334_bb0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40124-018-0161-z","article-title":"Opioid use disorders in adolescents-updates in assessment and management","volume":"6","author":"Yule","year":"2018","journal-title":"Current Pediatrics Reports"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:31:02Z","timestamp":1728603062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"alternative-id":["S2949875924000468"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209334","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209334"}}